| 产品详情 |
| Edit |   |
|---|
| Product Name | 3PO |
|---|
| Description | Originally reported to inhibit PFKFB3 (IC50 = 25 μM). More recent reports failed to demonstrate activity in a PFKFB3 kinase assay. Reduces glycolytic flux and suppresses glucose uptake. Inhibits endothelial cell proliferation and causes G2/M cell cycle arrest in vitro. Attenuates vessel sprouting and tumor growth in vivo. Amplifies the antiangiogenic effect of VEGFR blockade. Purity 99%. MW (observed): 210.23 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one |
|---|
| Gene, Accession, CAS # | CAS: 13309-08-5 |
|---|
| Catalog # | 5121/50 |
|---|
| Price | |
|---|
| Order / More Info | 3PO from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|